Lindsay Cassaro, PA
Physician Assistant · Frankfort, KYNPI 1124209317
Payments from drug & device makers
Across 108 payments — averaging $14.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$493
- Novo Nordisk$171
- Boehringer Ingelheim$135
- Lilly USA, LLC$132
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$95
- Pfizer$89
- plus $472 from 14 others
What the payments were for
- Food & beverage$1,587100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 44 | $493 |
| Novo Nordisk | 10 | $171 |
| Boehringer Ingelheim | 8 | $135 |
| Lilly USA, LLC | 8 | $132 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $95 |
| Pfizer | 5 | $89 |
| AstraZeneca | 5 | $87 |
| Otsuka America Pharmaceutical, Inc. | 3 | $62 |
| Abbott | 3 | $46 |
| Johnson & Johnson | 2 | $40 |
| Amgen | 2 | $36 |
| Astellas Pharma US Inc | 2 | $34 |
| GSK | 2 | $30 |
| Novartis | 2 | $29 |
| E.r. Squibb & Sons, L.L.C. | 1 | $23 |
| Kowa Pharmaceuticals America, Inc. | 1 | $21 |
| Azurity Pharmaceuticals, Inc. | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
| Exact Sciences | 1 | $16 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $14 |
How this compares
$1,587 in reported general payments places this provider in the 75th percentile of 1,448 physician assistant providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 80 | $103,923 |
| JardianceEmpagliflozin | 99 | $92,152 |
| MounjaroTirzepatide | 42 | $49,095 |
| EliquisApixaban | 51 | $43,174 |
| RybelsusSemaglutide | 19 | $23,869 |
| TradjentaLinagliptin | 30 | $22,662 |
| XareltoRivaroxaban | 18 | $22,329 |
| JanuviaSitagliptin Phosphate | 12 | $19,141 |
| Spiriva RespimatTiotropium Bromide | 11 | $16,697 |
| MyrbetriqMirabegron | 20 | $11,575 |
| LinzessLinaclotide | 13 | $10,990 |
| Repatha SureclickEvolocumab | 19 | $10,143 |
| SymbicortBudesonide/Formoterol Fumarate | 26 | $8,602 |
| SynthroidLevothyroxine Sodium | 58 | $4,284 |
| Duloxetine Hcl | 170 | $3,827 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance, Tradjenta, Spiriva Respimat | $135 | $131,511140 claims |
| Novo NordiskOzempic, Rybelsus | $171 | $127,79299 claims |
| Lilly USA, LLCMounjaro | $132 | $49,09542 claims |
| PfizerEliquis, Paxlovid | $89 | $44,51074 claims |
| Johnson & JohnsonXarelto | $40 | $22,32918 claims |
| AbbVieLinzess, Synthroid | $493 | $15,27471 claims |
| Astellas Pharma US IncMyrbetriq | $34 | $11,57520 claims |
| AstraZenecaSymbicort | $87 | $8,60226 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 1,448 physician assistant providers in Kentucky.
Other physician assistant in Frankfort
- Angela WilkinsFrankfort$12K
- Chrystal MeansFrankfort$8K
- Brandice HarrisonLexington$745K
- Lauren MeadeLexington$656K
- Melissa DavisLouisville$362K
- Kara MuddLouisville$98K
- Seth KingBowling Green$91K
- Marty MullinsHazard$63K
- Lauri GarnerVersailles$33K
- Robert TatumLouisville$29K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.